Stelara is a biologic medicine used to treat moderate to severe Crohn’s disease and ulcerative colitis. Crohn’s disease and ulcerative colitis are inflammatory bowel diseases that cause inflammation ...
Mirikizumab targets interleukin-23p19, reducing inflammation in ulcerative colitis and Crohn's disease, now approved for the full IBD spectrum. The VIVID-1 trial showed significant clinical remission ...
The American College of Gastroenterology (ACG) established clinical practice guidelines for the management of Crohn disease (CD) in adults. Treatment recommendations, which include FDA-approved and ...
In a recent study published in The New England Journal of Medicine, researchers discuss the results of a randomized clinical trial (RCT) comparing the therapeutic efficacy of risakizumab and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback